UK markets close in 6 hours 42 minutes
  • FTSE 100

    7,092.26
    +48.23 (+0.68%)
     
  • FTSE 250

    22,869.35
    +331.46 (+1.47%)
     
  • AIM

    1,190.46
    +8.84 (+0.75%)
     
  • GBP/EUR

    1.1817
    +0.0041 (+0.35%)
     
  • GBP/USD

    1.3344
    +0.0006 (+0.04%)
     
  • BTC-GBP

    42,643.64
    +1,743.58 (+4.26%)
     
  • CMC Crypto 200

    1,420.75
    -34.66 (-2.38%)
     
  • S&P 500

    4,594.62
    -106.84 (-2.27%)
     
  • DOW

    34,899.34
    -905.06 (-2.53%)
     
  • CRUDE OIL

    71.36
    +3.21 (+4.71%)
     
  • GOLD FUTURES

    1,800.30
    +12.20 (+0.68%)
     
  • NIKKEI 225

    28,283.92
    -467.70 (-1.63%)
     
  • HANG SENG

    23,852.24
    -228.28 (-0.95%)
     
  • DAX

    15,325.59
    +68.55 (+0.45%)
     
  • CAC 40

    6,787.98
    +48.25 (+0.72%)
     

LENSAR to Present at the H.C. Wainwright Ophthalmology Virtual Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

ORLANDO, Fla., August 16, 2021--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer will present at the H.C. Wainwright Ophthalmology Virtual Conference on August 17, 2021.

Mr. Curtis’ presentation will be available on-demand beginning at 7:00 a.m. Eastern Time on August 17, 2021 and can be accessed through the Investors section of the Company's website at https://ir.lensar.com. The webcast will be available for one month after the presentation has been posted.

About LENSAR

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210816005076/en/

Contacts

Thomas R. Staab, II, CFO
ir.contact@lensar.com

Lee Roth / Cameron Radinovic
Burns McClellan for LENSAR
lroth@burnsmc.com / cradinovic@burnsmc.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting